|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/00 | |
| A61K 31/17 | |||
| A61K 31/435 | |||
| A61K 39/00 | |||
| G01N 33/50 | |||
| G01N 33/574 | |||
| A61K 38/18 | |||
| A61K 31/44 | |||
| A61K 39/395 | |||
| A61K 38/02 |
| (11) | Patento numeris | 2726088 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12737394.2 |
| Europos patento paraiškos padavimo data | 2012-06-28 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-05-07 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-01-02 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2012/044673 |
| Data | 2012-06-28 |
| (87) | Numeris | WO 2013/003606 |
| Data | 2013-01-03 |
| (30) | Numeris | Data | Šalis |
| 201161502686 P | 2011-06-29 | US |
| (72) |
ANDERSON, Abraham, Antonio, US
WEINREICH, David, M., US
|
| (73) |
Amgen Inc.,
One Amgen Center Drive, Thousand Oaks, CA 91320-1799,
US
|
| (54) | PREDICTIVE BIOMARKER OF SURVIVAL IN THE TREATMENT OF RENAL CELL CARCINOMA |
| PREDICTIVE BIOMARKER OF SURVIVAL IN THE TREATMENT OF RENAL CELL CARCINOMA |